The store will not work correctly when cookies are disabled.
ID: ALA3407652
Max Phase: Preclinical
Molecular Formula: C19H28N2O3
Molecular Weight: 332.44
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CCN1CC(C)(C)OC(=O)C1CC(=O)Nc1ccc(C(C)C)cc1
Standard InChI: InChI=1S/C19H28N2O3/c1-6-21-12-19(4,5)24-18(23)16(21)11-17(22)20-15-9-7-14(8-10-15)13(2)3/h7-10,13,16H,6,11-12H2,1-5H3,(H,20,22)
Standard InChI Key: QPLWIEGBKHLNPO-UHFFFAOYSA-N
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Properties
Molecular Weight: 332.44 | Molecular Weight (Monoisotopic): 332.2100 | AlogP: 3.16 | #Rotatable Bonds: 5 |
Polar Surface Area: 58.64 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 6.15 | CX LogP: 3.30 | CX LogD: 3.28 |
Aromatic Rings: 1 | Heavy Atoms: 24 | QED Weighted: 0.84 | Np Likeness Score: -0.52 |
References
1. Bardiot D, Thevissen K, De Brucker K, Peeters A, Cos P, Taborda CP, McNaughton M, Maes L, Chaltin P, Cammue BP, Marchand A.. (2015) 2-(2-oxo-morpholin-3-yl)-acetamide derivatives as broad-spectrum antifungal agents., 58 (3): [PMID:25585716] [10.1021/jm501814x] |